Neupro® - Restless Legs Syndrome
In Europe, Neupro® is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.
Prescribing information Europe
In the US, Neupro® (Rotigotine Transdermal System) is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome.
For availability of Neupro® in other countries, please consult our local websites.